The Philadelphia digital and computation pathology solutions company released study results this week for its artificial intelligence technology, which highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases where pathologist agreement of biopsy results is low.
Proscia presented the data from the study, conducted at the University of Florida and Thomas Jefferson University in Philadelphia, at the European Conference on Computer Vision 2022.
Featured Story:
Latest Articles
October 1, 2024